BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37021542)

  • 21. Immunostaining of skin biopsy adds no diagnostic value in MGUS-associated peripheral neuropathy.
    Al-Zuhairy A; Schrøder HD; Plesner T; Abildgaard N; Sindrup SH
    J Neurol Sci; 2015 Feb; 349(1-2):60-4. PubMed ID: 25582978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
    Martín-Jiménez P; García-Sanz R; Balanzategui A; Alcoceba M; Ocio E; Sanchez ML; González M; San Miguel J
    Haematologica; 2007 May; 92(5):635-42. PubMed ID: 17488687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometry detection of CD138 expression continuum between monotypic B and plasma cells is associated with both high IgM peak levels and MYD88 mutation and contributes to diagnosis of Waldenström macroglobulinemia.
    Gayet M; Leymarie V; Derouault P; Guérin E; Vaidié J; Pascal V; Boulin M; Dmytruk N; Chauzeix J; Trimoreau F; Gachard N; Feuillard J; Rizzo D
    Cytometry B Clin Cytom; 2022 Jan; 102(1):62-69. PubMed ID: 33634586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia and description of its mutational profiles by targeted NGS.
    Garcia-Reyero J; Martinez Magunacelaya N; Gonzalez de Villambrosia S; Gomez Mediavilla A; Urquieta Lam M; Insunza A; Tonda R; Beltran S; Gut M; Gonzalez A; Montes-Moreno S
    J Clin Pathol; 2020 Sep; 73(9):571-577. PubMed ID: 31980558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.
    Mailankody S; Landgren O
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):187-193. PubMed ID: 27825465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
    Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
    Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia.
    Tedeschi A; Conticello C; Rizzi R; Benevolo G; Laurenti L; Petrucci MT; Zaja F; Varettoni M
    Hematol Oncol; 2019 Apr; 37(2):117-128. PubMed ID: 30192023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction.
    Jiménez C; Chillón Mdel C; Balanzategui A; Puig N; Sebastián E; Alcoceba M; Sarasquete ME; Conde IP; Corral R; Marín LA; Paiva B; Ruano M; Antón A; Maldonado R; San Miguel JF; González M; García-Sanz R
    Appl Immunohistochem Mol Morphol; 2014; 22(10):768-73. PubMed ID: 24992174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P.
    Zagaria A; Coccaro N; Tota G; Anelli L; Minervini A; Casieri P; Cellamare A; Minervini CF; Brunetti C; Ricco A; Orsini P; Cumbo C; Specchia G; Albano F
    Blood Cells Mol Dis; 2015 Jan; 54(1):51-2. PubMed ID: 25159121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The MYD88
    Kapoor P
    Br J Haematol; 2019 Nov; 187(4):413-415. PubMed ID: 31298748
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical, biological, electrophysiological and therapeutic profile of patients with anti-MAG neuropathy according to MYD88
    Guérémy A; Boucraut J; Boudjarane J; Grapperon AM; Fortanier E; Farnault L; Gabert J; Vely F; Lacroix R; Kouton L; Attarian S; Delmont E
    J Neurol; 2024 Mar; 271(3):1320-1330. PubMed ID: 37979093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neuropathies of Waldenström's macroglobulinemia (WM) and IgM-MGUS.
    Klein CJ; Moon JS; Mauermann ML; Zeldenrust SR; Wu Y; Dispenzieri A; Dyck PJ
    Can J Neurol Sci; 2011 Mar; 38(2):289-95. PubMed ID: 21320835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rare Circulating Cells in Familial Waldenström Macroglobulinemia Displaying the MYD88 L265P Mutation Are Enriched by Epstein-Barr Virus Immortalization.
    Pertesi M; Galia P; Nazaret N; Vallée M; Garderet L; Leleu X; Avet-Loiseau H; Foll M; Byrnes G; Lachuer J; McKay JD; Dumontet C
    PLoS One; 2015; 10(9):e0136505. PubMed ID: 26352266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive selection and high sensitivity test for MYD88 mutations using locked nucleic acid.
    Albitar A; Ma W; DeDios I; Estella J; Agersborg S; Albitar M
    Int J Lab Hematol; 2016 Apr; 38(2):133-40. PubMed ID: 26797804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropathy associated with monoclonal gammopathies of undetermined significance.
    Gosselin S; Kyle RA; Dyck PJ
    Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
    Schop RF; Van Wier SA; Xu R; Ghobrial I; Ahmann GJ; Greipp PR; Kyle RA; Dispenzieri A; Lacy MQ; Rajkumar SV; Gertz MA; Fonseca R
    Cancer Genet Cytogenet; 2006 Sep; 169(2):150-3. PubMed ID: 16938573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia.
    Grass S; Preuss KD; Wikowicz A; Terpos E; Ziepert M; Nikolaus D; Yang Y; Fadle N; Regitz E; Dimopoulos MA; Treon SP; Hunter ZR; Pfreundschuh M
    Blood; 2011 Mar; 117(10):2918-23. PubMed ID: 21220746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of peripheral neuropathy in plasma cell disorders.
    Silberman J; Lonial S
    Hematol Oncol; 2008 Jun; 26(2):55-65. PubMed ID: 18324611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.